genet
mutat
classifi
mani
way
one
impact
protein
function
simplest
term
mutat
result
protein
loss
function
gof
distinct
phenotyp
alway
clear
gof
research
context
usual
result
introduct
chang
biolog
agent
might
increas
abil
infect
host
caus
diseas
enhanc
transmiss
pathogen
recent
year
class
research
provok
controversi
particularli
set
dual
use
research
concern
durc
durc
subset
microbiolog
research
defin
us
govern
reason
anticip
provid
knowledg
inform
product
technolog
could
directli
misappli
pose
signific
threat
broad
potenti
consequ
public
health
safeti
agricultur
crop
plant
anim
environ
materiel
nation
secur
p
potenti
consequ
durc
cite
includ
manipul
pathogen
use
biolog
weapon
develop
mechan
pathogen
evad
countermeasur
durc
current
pertain
select
agent
toxin
defin
us
center
diseas
prevent
control
us
depart
agricultur
among
pathogen
highli
pathogen
avian
influenza
viru
hpai
high
concern
public
health
agricultur
author
public
discours
controversi
influenza
viru
research
decad
old
begin
reconstitut
influenza
recent
debat
safeti
merit
gof
research
first
surfac
context
studi
transmiss
dynam
hpai
figur
laboratori
univers
wisconsin
madison
erasmu
univers
medic
center
emc
rotterdam
netherland
perform
seri
experi
involv
mutat
influenza
strain
multipl
passag
two
laboratori
identifi
specif
amino
acid
chang
enhanc
airborn
transmiss
viru
standard
anim
influenza
model
exhibit
natur
histori
patholog
similar
observ
human
potenti
translat
ferret
human
rais
concern
among
funder
ie
nation
institut
health
nih
broader
biosecur
polici
commun
research
could
use
intent
harm
purpos
result
accident
releas
pathogen
laboratori
gener
popul
depart
health
human
servic
dhh
conven
nation
scienc
advisori
board
biosecur
nsabb
independ
feder
advisori
committe
charter
provid
advic
biosecur
oversight
dual
use
research
nsabb
ask
weigh
whether
gof
studi
publish
public
domain
initi
review
manuscript
one
submit
scienc
investig
emc
natur
investig
univers
wisconsin
nsabb
request
studi
author
journal
withhold
public
detail
studi
method
consequ
influenza
research
commun
voluntarili
implement
yearlong
moratorium
gof
research
march
nsabb
recommend
public
studi
minor
chang
emc
manuscript
deliber
led
creation
us
framework
durc
studi
stimul
debat
gof
research
within
scientif
commun
recent
influenza
viru
research
laid
rational
gof
experi
context
influenza
argument
met
critic
especi
respect
risk
accident
intent
releas
hpai
given
grow
concern
hpai
subtyp
white
hous
offic
scienc
technolog
polici
dhh
announc
moratorium
octob
new
fund
gof
research
influenza
virus
sever
acut
respiratori
syndrom
coronaviru
sarscov
middl
east
respiratori
syndrom
coronaviru
merscov
addit
us
govern
call
voluntari
moratorium
research
irrespect
fund
sourc
risk
benefit
experi
could
assess
decemb
nation
academi
scienc
nation
research
council
institut
medicin
conven
expert
disciplin
infecti
diseas
research
ethic
scienc
polici
discuss
potenti
risk
benefit
gof
research
public
forum
help
inform
feder
govern
best
proceed
regul
gof
research
potenti
danger
biolog
agent
shortli
meet
nih
notifi
subset
research
affect
research
paus
work
could
resum
specif
research
project
merscov
anim
model
develop
hpai
clear
continu
discuss
merit
risk
gof
research
limit
unit
state
dutch
court
appeal
recent
hand
verdict
concern
emc
object
export
licens
rule
regard
public
hpai
gof
research
export
licens
european
union
place
prevent
prolifer
weapon
mass
destruct
thu
appli
specif
biolog
agent
chemic
agent
technolog
dutch
govern
rule
emc
appli
export
licens
publish
gof
work
expedit
public
howev
emc
later
file
object
maintain
gof
research
context
basic
scientif
research
dutch
court
appeal
rule
emc
legal
stand
contest
export
licens
regul
address
legal
export
licens
leav
issu
open
continu
debat
current
gof
research
within
european
union
requir
export
licens
public
delib
review
process
head
nsabb
current
underway
evalu
potenti
impact
gof
research
set
criteria
type
research
conduct
made
avail
public
domain
larg
part
risk
analysi
like
involv
potenti
pathogen
misus
either
intent
accident
attempt
made
anticip
likelihood
latter
scenario
result
widerang
estim
recent
safeti
laps
center
diseas
control
prevent
nih
could
result
exposur
anthrax
smallpox
respect
diminish
public
confid
abil
even
highcontain
laboratori
mitig
risk
accident
releas
pathogen
potenti
harm
though
actual
risk
accident
releas
highli
pathogen
virus
may
low
public
toler
risk
may
ultim
determin
type
research
allow
proceed
increas
attent
brought
use
altern
method
investig
area
histor
studi
gof
research
altern
propos
reli
heavili
silico
technolog
comput
model
diseas
forecast
relev
method
import
consider
scientif
commun
medic
practition
gener
public
risk
benefit
approach
tangibl
outcom
yield
vari
accord
interest
need
sector
factor
consid
nsabb
decid
proceed
current
moratorium
futur
gof
research
gof
debat
transpir
date
ramif
research
practic
clinician
made
clear
develop
novel
prophylact
therapeut
intervent
invari
requir
evalu
anim
model
least
partial
recapitul
diseas
infect
human
mani
emerg
reemerg
zoonot
diseas
lack
relev
anim
model
close
recapitul
human
diseas
instanc
gof
experi
often
need
adapt
viru
isol
human
differ
sometim
unnatur
mammalian
host
adapt
new
host
inher
involv
alter
pathogen
mutat
develop
appropri
anim
model
ratelimit
step
evalu
prophylact
therapeut
intervent
gof
modif
viral
strain
import
tool
toward
acceler
product
develop
pipelin
coronavirus
sarscov
merscov
requir
meaning
smallanim
model
elucid
viral
pathogenesi
immun
human
isol
manipul
either
natur
evolut
target
mutat
repeat
exposur
human
factor
nonhuman
host
one
reliabl
sarscov
murin
model
develop
modifi
human
isol
serial
passag
lethal
young
mice
mouseadapt
viru
strain
contain
code
mutat
confer
increas
virul
approxim
mani
featur
sarscov
diseas
human
thu
provid
robust
reproduc
challeng
model
test
vaccin
antivir
intervent
develop
appropri
anim
model
merscov
hand
provid
uniqu
challeng
viral
receptor
use
cell
entri
radic
differ
mice
model
thu
far
includ
transient
transfect
transgen
mice
although
still
unclear
whether
model
accur
recapitul
human
infect
approxim
human
diseas
smallanim
model
might
requir
passag
presenc
human
receptor
thu
creat
potenti
develop
gof
phenotyp
mani
liveattenu
vaccin
includ
success
vaccin
ever
develop
gener
gof
research
polio
smallpox
influenza
liveattenu
vaccin
elicit
immun
authent
epitop
whole
pathogen
without
caus
diseas
liveattenu
measl
vaccin
creat
passag
viru
mutat
aros
alter
viru
techniqu
could
consid
current
definit
gof
research
new
research
highli
pathogen
virus
emphas
differ
way
gof
mutat
gener
evenmoreeffect
liveattenu
vaccin
mutat
within
rna
viru
polymeras
exampl
modifi
replic
fidel
gener
higher
lower
mutat
rate
viral
replic
fidel
mutant
could
potenti
alter
viral
tropism
modifi
key
antigen
increas
resist
novel
therapeut
intervent
antibodi
respons
could
also
lead
viru
less
fit
particular
type
experi
carri
rang
virus
includ
alphavirus
picornavirus
introduct
gof
mutat
attenu
viru
also
provid
improv
understand
mechan
viral
replic
thu
potenti
uncov
new
strategi
develop
vaccin
emerg
pathogen
gener
escap
mutant
presenc
investig
agent
common
practic
evalu
antibiot
antivir
monoclon
antibodi
gof
experi
hpai
highli
pathogen
human
influenza
virus
exampl
identifi
specif
mutat
confer
multidrug
resist
gof
experi
necessari
context
natur
occur
resist
strain
may
yet
exist
complex
background
natur
occur
mutat
may
preclud
identif
amino
acid
residu
critic
resist
gof
studi
equal
import
research
antivir
antibiot
help
inform
develop
combin
therapi
passiv
immunotherapi
often
includ
combin
product
particularli
depend
gof
experi
evalu
efficaci
seen
current
ebola
outbreak
prompt
robust
program
evalu
combin
monoclon
antibodi
therapi
past
halfcenturi
gof
research
contribut
improv
understand
epidemiolog
emerg
pathogen
inform
effort
conduct
surveil
futur
outbreak
context
influenza
data
deriv
gof
research
rel
transmiss
hemagglutinin
mutat
aid
interpret
molecular
surveil
data
specif
initi
influenza
later
influenza
experi
identifi
amino
acid
chang
influenza
viru
hemagglutinin
rna
polymeras
viral
passag
sitedirect
mutagenesi
research
elucid
mechan
natur
occur
influenza
viru
strain
might
evolv
replic
effici
transmit
easili
within
mammalian
host
result
experi
use
crossrefer
trait
found
among
circul
strain
help
predict
transmiss
pattern
pathogen
field
diseas
surveil
evolv
accommod
grow
repositori
viral
sequenc
gof
research
also
play
import
role
assess
public
health
signific
genotyp
variat
though
current
understand
relationship
genotyp
data
phenotyp
express
suboptim
increas
relianc
clinic
commun
molecular
diagnost
tool
may
help
reduc
uncertainti
cost
wholegenom
sequenc
continu
decreas
data
techniqu
like
becom
central
diseas
surveil
program
result
gof
experiment
also
help
inform
decis
countermeasur
select
stockpil
particularli
context
influenza
surveil
program
improv
understand
hpai
evolv
transmit
effici
also
factor
decis
creation
prepandem
vaccin
stockpil
world
wit
number
emerg
infecti
diseas
pandem
past
sever
decad
time
clinic
public
health
practition
front
line
provid
care
treatment
find
way
interrupt
transmiss
ultim
respons
contain
outbreak
healthcar
provid
requir
effect
medic
countermeasur
epidemiolog
inform
assess
risk
support
decis
treatment
prevent
recent
outbreak
infect
due
ebola
viru
merscov
pandem
influenza
viru
howev
continu
demonstr
medic
public
health
readi
emerg
infect
alway
optim
could
benefit
research
develop
outlin
gof
research
play
signific
role
ensur
clinician
tool
need
respond
infecti
diseas
outbreak
therefor
clinic
commun
directli
affect
polici
decis
type
research
allow
continu
also
risk
associ
gof
research
clinic
commun
acut
awar
recent
laps
highprofil
laboratori
illustr
remain
potenti
bacteri
viral
strain
escap
even
secur
environ
pathogen
escap
whether
natur
occur
product
gof
research
clinic
commun
import
role
detect
respond
incid
uniqu
role
beneficiari
product
gof
research
mitig
risk
clinician
vital
stake
public
debat
gof
research
proceed
